AYTU BIOPHARMA, INC Restricted Investments, at Fair Value
AYTU BIOPHARMA, INC (AYTU) had Restricted Investments, at Fair Value of $1.40 million as of 2017-09-30, per its 10-Q filed 2018-02-08.
Discontinued › Notes › SEC Schedule › Schedule of Investments
us-gaap:RestrictedInvestmentsAtFairValue · last filed 2018-02-08
- 2017-09-30: Restricted Investments, at Fair Value $1.40M; Restricted Investments, at Fair Value as first filed $404.00K.
| Period end | Restricted Investments, at Fair Value | Restricted Investments, at Fair Value as first filed |
|---|---|---|
| 2017-09-30 | $1.40M 10-Q · filed 2018-02-08 | $404.00K 10-Q · filed 2017-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |